Espinoza Octavio bought LGND
February 28, 2024 · Form 4 insider transaction
Espinoza Octavio bought 140 shares of Ligand Pharmaceuticals Incorporated at $57.22 per share, a transaction worth $8.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
140
Price
$57.22
Total value
$8.0K
InsiderEspinoza Octavio
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 28, 2024
Filing dateFebruary 29, 2024
Shares owned after29,570
OwnershipDirect
10b5-1 planNo
AmendedNo